Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
2(100.0%)
2Total
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06462781Phase 1Completed

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Role: collaborator

NCT06510582Phase 1Recruiting

Chronic Subdural Hematoma Treatment With Intra-Arterial Bevacizumab Injection

Role: collaborator

NCT04096248Completed

CT (Computerized Tomography) for Late EndovasculAr Reperfusion

Role: collaborator

NCT04895462Completed

Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19

Role: collaborator

All 4 trials loaded